Acta Pharmaceutica Sinica B (May 2019)

Aurone derivatives as Vps34 inhibitors that modulate autophagy

  • Guodong Li,
  • Joshua William Boyle,
  • Chung-Nga Ko,
  • Wu Zeng,
  • Vincent Kam Wai Wong,
  • Jian-Bo Wan,
  • Philip Wai Hong Chan,
  • Dik-Lung Ma,
  • Chung-Hang Leung

Journal volume & issue
Vol. 9, no. 3
pp. 537 – 544

Abstract

Read online

We report in this study the identification of a natural product-like antagonist (1a) of Vps34 as a potent autophagy modulator via structure-based virtual screening. Aurone derivative 1a strongly inhibited Vps34 activity in cell-free and cell-based assays. Significantly, 1a prevents autophagy in human cells induced either by starvation or by an mTOR inhibitor. In silico modeling and kinetic data revealed that 1a could function as an ATP-competitive inhibitor of Vps34. Moreover, it suppressed autophagy in vivo and without inducing heart or liver damage in mice. 1a could be utilized as a new motif for more selective and efficacious antagonists of Vps34 for the potential treatment of autophagy-related human diseases. KEY WORDS: Autophagy, Natural products, Vps34, Inhibitor, Structure-based virtual screening, Vesicle trafficking, Heart or liver damage, Aurone derivative